Showing results (91-100 of 103) with videos related to
Sort By:
Pageof 11
Journal of Hematology & Oncology|May 20, 2020
Correction to: Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemiaHanren Dai, Zhiqiang Wu, Hejin Jia, et al.Science China. Life Sciences|March 25, 2016
An analytical biomarker for treatment of patients with recurrent B-ALL after remission induced by infusion of anti-CD19 chimeric antigen receptor T (CAR-T) cellsYajing Zhang, Wenying Zhang, Hanren Dai, et al.Nature Communications|April 15, 2026
Demethylation-primed tandem CD19/CD20 CAR T cells in relapsed/refractory B-cell lymphoma: a phase I/II trialChunmeng Wang, Yelei Guo, Fuxin Han, et al.Annals of Translational Medicine|December 22, 2022
Oncogenic alterations reveal key strategies for precision oncology in melanoma treatmentWei Sun, Fang Zhao, Tu Hu, et al.Cell Reports. Medicine|December 31, 2025
Discovery, delineation, and therapeutic targeting of a hyper-translation pathway driving cytokine release syndromeXingxian Liu, Jiaqi Li, Yajing Zhang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2019
Addition of Low-Dose Decitabine to Anti-PD-1 Antibody Camrelizumab in Relapsed/Refractory Classical Hodgkin LymphomaJing Nie, Chunmeng Wang, Yang Liu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2011
MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancerBiqiang Zheng, Linhui Liang, Chunmeng Wang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2022
Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II StudyXin Liu, Shiyu Jiang, Huijie Wang, et al.Oncoimmunology|October 10, 2015
Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemiaHanren Dai, Wenying Zhang, Xiaolei Li, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2025
Anlotinib versus Placebo as Adjuvant Therapy for Localized High-Grade Soft-Tissue Sarcomas: A Phase II, Double-Blinded, Randomized Controlled TrialChunmeng Wang, Xianglin Hu, Lingge Yang, et al.Pageof 11